4//SEC Filing
Ng George K 4
Accession 0000897069-23-001136
CIK 0001533743other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 4:51 PM ET
Size
7.3 KB
Accession
0000897069-23-001136
Insider Transaction Report
Form 4
Ng George K
DirectorChief Executive Officer
Transactions
- Award
Restricted Stock Units
2023-08-08+400,000→ 400,000 totalExercise: $0.00→ Common Stock (400,000 underlying) - Award
Restricted Stock Units
2023-08-08+400,000→ 800,000 totalExercise: $0.00→ Common Stock (400,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting of one-third on 08/08/24, 08/08/25, and 08/08/26 or upon a change in control event.
- [F2]The restricted stock units vest upon the achievement of certain performance goals.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001638744
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 4:51 PM ET
- Size
- 7.3 KB